Search
Schizoaffective Disorder Clinical Trials
A listing of 29 Schizoaffective Disorder clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
25 - 29 of 29
There are currently 29 active clinical trials seeking participants for Schizoaffective Disorder research studies. The states with the highest number of trials for Autism participants are California, New York, Texas and Massachusetts.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Bipolar Disorder Study (Medicare Required)
Recruiting
Non-drug Bipolar Depression study for adults with Medicare. If you have Bipolar Disorder, are over the age of 18, and are currently depressed, you may be eligible to take part in this study. If you have tried at least four treatments and not found them helpful, you are a good candidate for this study. All study-related care will be provided at no cost to you.
Conditions:
Bipolar Disorder
Bipolar Depression
Bipolar I Disorder
Depression
Bipolar
Sodium Nitroprusside in Early Course Schizophrenia
Recruiting
Peripheral inflammation and microvascular dysfunction are central to the pathophysiology of schizophrenia (SZ). Retinal imaging allows for the accurate quantitative assessment of the condition of retinal microvessels, and early studies implicate microvascular dysfunction in SZ, but the specific pathophysiological mechanisms underlying greater length, density, capillary network and diameter are not yet entirely understood. Anti-inflammatory drug trials in SZ suggest that Early Course Schizophreni... Read More
Gender:
All
Ages:
Between 18 years and 40 years
Trial Updated:
05/12/2023
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Schizophrenia, Schizoaffective Disorder
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Recruiting
The purpose of this study is to determine if taking a synbiotic supplement versus a placebo will reduce symptoms of schizophrenia when used in addition to standard antipsychotic medications.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
04/19/2023
Locations: Sheppard Pratt Health System, Baltimore, Maryland
Conditions: Schizophrenia, Schizoaffective Disorder
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Recruiting
The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
04/03/2023
Locations: Psychiatric Hospital at Vanderbilt, Nashville, Tennessee
Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Major Depression
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
Recruiting
Treatment of schizophrenia currently includes antipsychotic medications and cognitive therapies which improve some symptoms, but do not sufficiently restore cognitive functioning or reduce psychosocial disability. We hypothesize that medications that specifically target sensory information processing deficits, rather than psychotic symptoms per se, will significantly enhance the benefits of a sensory-based targeted cognitive training (TCT) intervention in patients with schizophrenia. We will com... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/21/2023
Locations: Clinical Teaching Facility (CTF B-403 at UCSD Medical Center), San Diego, California
Conditions: Schizophrenia, Schizoaffective Disorder
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Recruiting
To test the feasibility of studying effects of smoking cessation with varenicline on antipsychotic drug-induced neurological side effects, we propose a 12 week pilot study of smoking cessation treatment with varenicline in 10 schizophrenia or schizoaffective disorder patients who are actively smoking and have pre-existing TD while receiving stable doses of antipsychotics. Subjects will be followed after a 2 week baseline period to assess changes in smoking status and neurological symptoms using... Read More
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
03/20/2019
Locations: Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania
Conditions: Schizophrenia, Schizoaffective Disorder, Tobacco Smoking, Tardive Dyskinesia, Parkinsonism
25 - 29 of 29